Bechien U Wu1, Richard S Johannes, Stephen Kurtz, Peter A Banks. 1. Division of Gastroenterology, Brigham and Women's Hospital, Center for Pancreatic Disease, Harvard Medical School, Boston, Massachusetts 02115, USA. buwu@partners.org
Abstract
BACKGROUND & AIMS: Little is known regarding the impact of hospital-acquired infection (HAI) in acute pancreatitis (AP). We conducted a population-based assessment of the impact of HAI on outcome in AP. METHODS: Patient data were obtained from the Cardinal Health Clinical Outcomes Research Database, a large population-based data set. Cases with principal diagnosis by International Classification of Diseases, ninth revision, clinical modification 577.0 (AP) between January 2004 and January 2005 were identified. These cases were linked with recently reported HAI data collected by the Pennsylvania Health Care Cost Containment Council. Identification of HAI was based on definitions set forth by the National Nosocomial Infection Surveillance System. We conducted a 5:1 multivariate propensity-matched cohort study to determine the independent contribution of HAI to in-hospital mortality, length of stay (LOS), and hospital charges. RESULTS: From 177 participating hospitals, there were 11,046 AP cases identified. Eighty-two (0.7%) patients developed an HAI. Mortality in the overall AP population was 1.2% vs 11.4% among 405 matched non-HAI controls vs 28.4% among patients who developed HAI (chi(2) test, P < .0001). Fifteen percent of all deaths was associated with an HAI. Both average LOS and hospital charges were significantly increased among patients with HAI compared with matched non-HAI controls. CONCLUSIONS: We determined that HAI had a major impact on mortality in AP. Patients who developed HAI also had significantly increased LOS and hospital charges. These differences were not explained by increased disease severity alone. Reducing HAI is an important step to improving outcome in AP.
BACKGROUND & AIMS: Little is known regarding the impact of hospital-acquired infection (HAI) in acute pancreatitis (AP). We conducted a population-based assessment of the impact of HAI on outcome in AP. METHODS:Patient data were obtained from the Cardinal Health Clinical Outcomes Research Database, a large population-based data set. Cases with principal diagnosis by International Classification of Diseases, ninth revision, clinical modification 577.0 (AP) between January 2004 and January 2005 were identified. These cases were linked with recently reported HAI data collected by the Pennsylvania Health Care Cost Containment Council. Identification of HAI was based on definitions set forth by the National Nosocomial Infection Surveillance System. We conducted a 5:1 multivariate propensity-matched cohort study to determine the independent contribution of HAI to in-hospital mortality, length of stay (LOS), and hospital charges. RESULTS: From 177 participating hospitals, there were 11,046 AP cases identified. Eighty-two (0.7%) patients developed an HAI. Mortality in the overall AP population was 1.2% vs 11.4% among 405 matched non-HAI controls vs 28.4% among patients who developed HAI (chi(2) test, P < .0001). Fifteen percent of all deaths was associated with an HAI. Both average LOS and hospital charges were significantly increased among patients with HAI compared with matched non-HAI controls. CONCLUSIONS: We determined that HAI had a major impact on mortality in AP. Patients who developed HAI also had significantly increased LOS and hospital charges. These differences were not explained by increased disease severity alone. Reducing HAI is an important step to improving outcome in AP.
Authors: Kathleen G Julian; Arlene M Brumbach; Michelle K Chicora; Carol Houlihan; Anna M Riddle; Teanna Umberger; Cynthia J Whitener Journal: Infect Control Hosp Epidemiol Date: 2006-08-14 Impact factor: 3.254
Authors: Peter Götzinger; Thomas Sautner; Stephan Kriwanek; Philipp Beckerhinn; Murat Barlan; Christian Armbruster; Peter Wamser; Reinhold Függer Journal: World J Surg Date: 2002-02-06 Impact factor: 3.352
Authors: Josep Maria Haro; Stathis Kontodimas; Miguel Angel Negrin; Mark Ratcliffe; David Suarez; Frank Windmeijer Journal: Appl Health Econ Health Policy Date: 2006 Impact factor: 2.561
Authors: J Ruben Rodriguez; A Oswaldo Razo; Javier Targarona; Sarah P Thayer; David W Rattner; Andrew L Warshaw; Carlos Fernández-del Castillo Journal: Ann Surg Date: 2008-02 Impact factor: 12.969
Authors: Rupjyoti Talukdar; Pankaj Ingale; Hrushikesh P Choudhury; Rajan Dhingra; Shiran Shetty; Harshad Joshi; K R Pradeep; Lalatendu Mahapatra; Subhasish Mazumder; J K Pradeep; Bhavesh Thakker; Adarsh Chaudhary; Ajay Kumar; D Nageshwar Reddy; G V Rao; H Ramesh; Naresh Bhat; Pramod Garg; Rakesh Kochhar Journal: Indian J Gastroenterol Date: 2014-08-21
Authors: Noor L H Bekkali; Sam Murray; Lesley Winter; Vinay Sehgal; George J M Webster; Michael H Chapman; Steven Bandula; Zahir Amin; Samantha Read; Stephen P Pereira; Gavin J Johnson Journal: Frontline Gastroenterol Date: 2016-09-05
Authors: Antti Turunen; Antti Kuuliala; Harri Mustonen; Pauli Puolakkainen; Leena Kylänpää; Krista Kuuliala Journal: Pancreas Date: 2021 May-Jun 01 Impact factor: 3.327
Authors: Olaf J Bakker; Hjalmar C van Santvoort; Sandra van Brunschot; Usama Ahmed Ali; Marc G Besselink; Marja A Boermeester; Thomas L Bollen; Koop Bosscha; Menno A Brink; Cornelis H Dejong; Erwin J van Geenen; Harry van Goor; Joos Heisterkamp; Alexander P Houdijk; Jeroen M Jansen; Thom M Karsten; Eric R Manusama; Vincent B Nieuwenhuijs; Bert van Ramshorst; Alexander F Schaapherder; George P van der Schelling; Marcel Bm Spanier; Adriaan Tan; Juda Vecht; Bas L Weusten; Ben J Witteman; Louis M Akkermans; Hein G Gooszen Journal: Trials Date: 2011-03-10 Impact factor: 2.279
Authors: Mariusz Rosołowski; Michał Lipiński; Marek Dobosz; Marek Durlik; Stanisław Głuszek; Katarzyna Kuśnierz; Paweł Lampe; Ewa Małecka-Panas; Ewa Nowakowska-Duława; Magdalena Nowak-Niezgoda; Barbara Radomańska; Renata Talar-Wojnarowska; Urszula Wereszczyńska-Siemiątkowska; Grażyna Rydzewska Journal: Prz Gastroenterol Date: 2016-06-08